Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
1300
mi
from 91732
Omaha, NE
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1300
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
2032
mi
from 91732
Cleveland, OH
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
1959
mi
from 91732
Columbus, OH
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
1877
mi
from 91732
Fairfield, OH
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1877
mi
from 91732
Fairfield, OH
Click here to add this to my saved trials
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
1225
mi
from 91732
Dallas, TX
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
686
mi
from 91732
El Paso, TX
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
686
mi
from 91732
El Paso, TX
Click here to add this to my saved trials
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  12/31/1969
6113
mi
from 91732
Capital Federal,
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 12/31/1969
Investigational Site Number 032001
6113
mi
from 91732
Capital Federal,
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
1777
mi
from 91732
Birmingham, AL
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
329
mi
from 91732
Palo Alto, CA
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Stanford University
329
mi
from 91732
Palo Alto, CA
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
2486
mi
from 91732
New Haven, CT
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Yale University
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
1919
mi
from 91732
Atlanta, GA
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Emory University
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
1791
mi
from 91732
Indianapolis, IN
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Indiana University
1791
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
1527
mi
from 91732
Iowa City, IA
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
University of Iowa
1527
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
2578
mi
from 91732
Boston, MA
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
1965
mi
from 91732
Detroit, MI
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Wayne State University
1965
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
648
mi
from 91732
Albuquerque, NM
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
648
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
2204
mi
from 91732
Durham, NC
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
RTI International
2204
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
2203
mi
from 91732
Durham, NC
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Duke University
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
1880
mi
from 91732
Cincinnati, OH
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Medical Center
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
2036
mi
from 91732
Cleveland, OH
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve Univ
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
2562
mi
from 91732
Providence, RI
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
2562
mi
from 91732
Providence, RI
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
1221
mi
from 91732
Dallas, TX
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
1221
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
1352
mi
from 91732
Houston, TX
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
1352
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated:  12/31/1969
572
mi
from 91732
Salt Lake City, UT
Hypotension in Neonates
Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study
Status: Enrolling
Updated: 12/31/1969
University of Utah
572
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
99
mi
from 91732
La Jolla, CA
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
99
mi
from 91732
La Jolla, CA
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
364
mi
from 91732
Sacramento, CA
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
364
mi
from 91732
Sacramento, CA
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
1528
mi
from 91732
Iowa City, IA
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1528
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
2301
mi
from 91732
Baltimore, MD
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
2578
mi
from 91732
Boston, MA
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
2032
mi
from 91732
Cleveland, OH
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
1959
mi
from 91732
Columbus, OH
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
1225
mi
from 91732
Dallas, TX
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated:  12/31/1969
5749
mi
from 91732
Corrientes,
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
Long-term Extension, Multicentre, Multi-international Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg, 1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Status: Enrolling
Updated: 12/31/1969
5749
mi
from 91732
Corrientes,
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
1777
mi
from 91732
Birmingham, AL
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
343
mi
from 91732
Phoenix, AZ
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Arizona Pulmonary Specialist
343
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
347
mi
from 91732
Phoenix, AZ
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Phoenix
347
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
212
mi
from 91732
Fresno, CA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of California San Francisco-Fresno
212
mi
from 91732
Fresno, CA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
25
mi
from 91732
Los Angeles, CA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
West Los Angeles VA Healthcare Center
25
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
366
mi
from 91732
Sacramento, CA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
UC Davis Medical Center
366
mi
from 91732
Sacramento, CA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
105
mi
from 91732
San Diego, CA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
UCSD Medical Center
105
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
328
mi
from 91732
Stanford, CA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Stanford University, Pulmonary and Critical Care
328
mi
from 91732
Stanford, CA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
23
mi
from 91732
Torrance, CA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Harbor UCLA Medical Center
23
mi
from 91732
Torrance, CA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
825
mi
from 91732
Aurora, CO
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Pulmonary Hypertension Clinic
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
2127
mi
from 91732
Jacksonville, FL
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Florida - Jacksonville
2127
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
2303
mi
from 91732
Weston, FL
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Florida
2303
mi
from 91732
Weston, FL
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
1922
mi
from 91732
Atlanta, GA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Emory University School of Medicine
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
1730
mi
from 91732
Chicago, IL
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Chicago
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
1528
mi
from 91732
Iowa City, IA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Iowa Health Care
1528
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
1813
mi
from 91732
Louisville, KY
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Kentuckiana Pulmonary Associates
1813
mi
from 91732
Louisville, KY
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
1494
mi
from 91732
Alexandria, LA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Alexandria Cardiology Clinic
1494
mi
from 91732
Alexandria, LA
Click here to add this to my saved trials